ストックスクリーナーアプリを入手
17.63
6.37%
-1.21
前日終値:
$18.84
開ける：
$19.02
24時間の取引高:
375.26K
Relative Volume:
1.36
時価総額：
$473.10M
収益：
$31.38M
当期純損益:
$-6.69M
株価収益率:
-67.81
EPS:
-0.26
ネットキャッシュフロー:
$-1.84M
1週間 パフォーマンス:
-11.98%
1か月 パフォーマンス:
+1.73%
6か月 パフォーマンス:
+49.24%
1年 パフォーマンス:
+385.95%
1日の値動き範囲:
$17.26
$19.02
1週間の範囲:
$17.26
$21.10
52週間の値動き範囲:
$3.18
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
名前
Eton Pharmaceuticals Inc
セクター
電話
(847) 787-7361
住所
21925 W. FIELD PARKWAY, DEER PARK, IL
ETON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
17.64 | 537.42M | 31.38M | -6.69M | -1.84M | -0.26 |
|
HLN
Haleon Plc Adr
|
11.06 | 50.54B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
170.75 | 74.02B | 9.29B | 2.52B | 2.28B | 5.57 |
|
RDHL
Redhill Biopharma Ltd Adr
|
1.8576 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.95 | 45.82B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.18 | 20.31B | 16.54B | -1.64B | 749.00M | -1.45 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | B. Riley Securities | Buy |
| 2025-01-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-09-04 | 再開されました | H.C. Wainwright | Buy |
| 2024-05-06 | 開始されました | Craig Hallum | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-01-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-09-20 | 開始されました | B. Riley FBR | Buy |
| 2019-06-10 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Eton Pharmaceuticals Inc (ETON) 最新ニュース
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why - MSN
Millennium Management LLC Acquires New Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Equities Analysts Offer Predictions for ETON Q3 Earnings - Defense World
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency - MSN
Eton Pharmaceuticals (ETON) Target Price Raised to $35 by HC Wai - GuruFocus
Eton Pharmaceuticals Inc (ETON) Shares Down 4.98% on May 29 - GuruFocus
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue - Benzinga
Sector Update: Health Care - marketscreener.com
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI By Investing.com - Investing.com South Africa
Northern Trust Corp Purchases 22,827 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI - Investing.com Australia
Eton Pharma stock gains on FDA nod for Khindivi (ETON:NASDAQ) - Seeking Alpha
Eton Pharmaceuticals (ETON) Price Target Raised After FDA Approval | ETON Stock News - GuruFocus
Eton Pharmaceuticals Gains FDA Approval for KHINDIVI - TipRanks
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution - GlobeNewswire
Trading (ETON) With Integrated Risk Controls - news.stocktradersdaily.com
Jane Street Group LLC Has $857,000 Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week - Yahoo Finance
Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Shares Up 3.33% on May 19 - GuruFocus
Balyasny Asset Management L.P. Invests $158,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Q3 EPS Estimates for Eton Pharmaceuticals Cut by B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Earns “Buy” Rating from B. Riley - Defense World
Eton Pharmaceuticals Inc (ETON) Shares Down 3.4% on May 16 - GuruFocus
(ETON) Trading Report - news.stocktradersdaily.com
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $28.00 - Defense World
HC Wainwright Has Negative Outlook of ETON Q2 Earnings - Defense World
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Secu - GuruFocus
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Securities | ETON Stock News - GuruFocus
Eton Pharmaceuticals (ETON) Price Target Boosted Following Strong Q1 Results | ETON Stock News - GuruFocus
Results: Eton Pharmaceuticals, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts - simplywall.st
B. Riley Raises Price Target on Eton Pharmaceuticals to $26 From $24, Keeps Buy Rating - marketscreener.com
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 12% After Analyst Upgrade - Defense World
Eton outlines path to $100M near-term revenue with ET-400 launch and Increlex growth - MSN
Eton Pharmaceuticals’ Earnings Call: Growth and Prospects - TipRanks
Eton Pharmaceuticals (ETON) Price Target Raised by Craig-Hallum | ETON Stock News - GuruFocus
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2025 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 12-Month High Following Analyst Upgrade - Defense World
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire
Eton Pharmaceuticals CEO to Lead Fireside Chat at Major Investor Conferences: How to Schedule 1-on-1 Meetings - Stock Titan
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates - MSN
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts - Benzinga
Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight - Nasdaq
Eton Pharmaceuticals (ETON) Surpasses Q1 Revenue Expectations wi - GuruFocus
Eton Pharmaceuticals: Buy Rating Backed by Successful Relaunches and Promising Growth Prospects - TipRanks
Raymond James Financial Inc. Takes $147,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Eton Pharmaceuticals (ETON) Projects Strong Growth with New Acqu - GuruFocus
Eton Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Eton Pharmaceuticals Q1 2025 beats revenue estimates - Investing.com Nigeria
Eton Pharmaceuticals Inc (ETON) 財務データ
収益
当期純利益
現金流量
EPS
Eton Pharmaceuticals Inc (ETON) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Oct 23 '24 |
Buy |
7.98 |
10,000 |
79,814 |
2,770,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 08 '24 |
Buy |
7.03 |
33,970 |
238,782 |
2,760,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 04 '24 |
Buy |
6.77 |
16,852 |
114,105 |
2,720,000 |
| Opaleye Management Inc. | 10% Owner |
Oct 07 '24 |
Buy |
7.22 |
11,248 |
81,250 |
2,730,000 |
| Opaleye Management Inc. | 10% Owner |
Sep 10 '24 |
Buy |
4.65 |
57,500 |
267,375 |
2,660,000 |
| Opaleye Management Inc. | 10% Owner |
Sep 11 '24 |
Buy |
4.75 |
50,000 |
237,500 |
2,705,000 |
3.28%
2.99%
大文字化:
|
ボリューム (24 時間):